Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

41,693 stories, page 465 of 695

Advanced search

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT07720076: Effectiveness of Breastfeeding Education Using a Lactation Simulation Model Among Nursing Students: A Randomized Controlled Trial

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT07720063: Group Treatment for Self-harming Adolescents and Their Parents: a Randomized Controlled Trial

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT07719959: A Randomized Controlled Trial of 3D Airway Reconstruction for Precise Double-Lumen Bronchial Intubation

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT07719790: Does Erectile Dysfonction Allow to Evaluate Subendocardial Viability Among Treated Patients With Hypertension ?

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT07719504: IMPLEMENTATION OF PHYSICAL THERAPY PROTOCOL FOR FUNCTIONAL CONSTIPATION

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT07719296: HIIT, Cardiorespiratory Fitness, and Metabolic Health in Healthy Young Adults

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT07719257: Evaluation of the Safety, Tolerability and Pharmacokinetics of TUL108 for Injection in Healthy Participants (SAD/ MAD)

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT07719088: Psilocybin Effects on Healthy Aging Biomarkers and Purpose in Life

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT07719062: AI Chatbot for Prostate Radiation Therapy Patient Education

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT07718490: Immunotheray Combined With Simvastatin and Target Therapy and Chemotharepy for Advanced Colorectal Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT07717710: Ivabradine for Heart Rate Reduction During Exercise in Healthy Adults

Study type: INTERVENTIONAL. Phase: EARLY_PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT07715396: Addition of Platinum-based Chemotherapy to Tislelizumab in PD-L1high Metastatic Non-small Cell Lung Cancer With a High Tumor Burden

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT07711691: Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+)

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT07702617: Effects Of Vacuum Controlled Static Versus Vacuum Controlled Dynamic Dry Cupping On Pain, Range Of Motion And Disability Among Patients With Chronic Low Back Pain

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT07684066: D-TECT: Pretreatment D-dimers and Disease Control in Advanced cSCC Treated With Cemiplimab

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT07648264: Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT07621640: Brown Adipose Tissue as a Mechanistic Determinant of Semaglutide Treatment Response in Obesity (BAT-Sema Study)

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT07607678: A Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are Tolerated When Taken Alone and Together With Ezabenlimab

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT07516379: GRAfT 2.0. A Multimodal Prospective Approach to Define the Mechanisms and Clinical Features of Acute and Chronic Rejection in Lung Transplantation

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT07430904: Empowerment Program to Reduce Treatment of Asymptomatic Bacteriuria in Veterans With Spinal Cord Injury

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT07239947: A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT07224425: A Study of BI 3810944 in Patients With Advanced Cancer

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT07216456: Vaginal Dilator Therapy After Pelvic Radiation

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT07201896: [Trial of device that is not approved or cleared by the U.S. FDA]

Study type: . Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT07194707: Effect of Operating Room Noise on BIS and Hemodynamics Under General Anesthesia

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT07155174: A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT07118215: A Study to Evaluate the Effects of KarXT on the Drug Levels of Midazolam, Fexofenadine, and Digoxin

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT06758401: This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT06733649: Treatment Education for Perinatal Women and Their Community Support

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT06583577: Ostomy Simulation for Patient Education Prior to Urologic Bowel Diversion Surgeries

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT06502990: Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised Lipodystrophy

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT06471920: Improving Health for Patients With Chronic Low Back Pain in Rural Communities Through Telerehabilitation

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT06468618: Developing Restful Environments and Management Strategies for Pediatric Stem Cell Transplant Patients

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT06453213: Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy

Study type: INTERVENTIONAL. Phase: PHASE4.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT06371417: Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT06133387: PARADIGM - En Bloc Trial With the EndoQuest Endoluminal Surgical (ELS) System

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT06029270: Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT06013423: Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT05879250: WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT05506423: Study of the CycloPen Micro-Interventional System and Long-Term Clinical Outcomes

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT05266417: Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT05142189: Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT04879329: A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT04285086: Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT01059786: Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Researchclinicaltrials.govTier 1 · Trial registry

NCT00076310: OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 22Industryarrowheadpharma.comTier 1 · Company source

Arrowhead Pharmaceuticals Reports Topline Results from Phase 3 SHASTA-3 and SHASTA-4 Studies of Plozasiran in Patients with Severe Hypertriglyceridemia

Deep, durable, and consistent median triglyceride reductions of 79% and 81% from baseline in SHASTA...

Arrowhead PharmaceuticalsOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Enliven Therapeutics' Soaring Stock Faces a $570,000 Insider Reality Check

Kavout | AIOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Wall Street can wait: Why one U.S. biotech firm is listing in Hong Kong first

CNBCOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Aribio to Present AR1001 Phase 3 Results in First Session at CTAD 2026 Opening

아시아경제Original source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Trump says generic drugs to face no US tariffs for 2 years, then 100% and 200% tariffs later

ReutersOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Fervor over top-selling drugs fuels biotech dealmaking

SemaforOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Cambium Bio Raises AUD 1.008 Million via Placement to Fund Phase 3 Elate Ocular Trial

KalkineOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Radiopharm Theranostics Achieves 93% Concordance in Phase 2b Trial of RAD101 for Brain Metastases Diagnosis

KalkineOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Regeneron Pharmaceuticals, Inc. (REGN) Faces Securities Class Action Amid Disclosures About Key Trial's Protocol and Ultimate Failure - HBSS

TradingViewOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Senate Panel Examines China's Influence on U.S. Drug Supply Chain

Legis1Original source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

News | DivcoWest lands biotech headquarters deal at revamped Boston tower

CoStarOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

On the run for 20 years, most-wanted fugitive caught hiding as a biotech exec

Ars TechnicaOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

PharmAla Biotech Executes Definitive License Agreement Granting Jupiter Neurosciences Exclusive U.S. Rights to ALA-002

Investing News NetworkOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

AI toxicity prediction: What machine learning models can (and can't) tell you about drug safety

Drug Discovery NewsOriginal source